Western blot analysis showed that following L-Lac treatment, the expression levels of proliferation markers PCNA and cyclin D1 and of the Bcl-2 in GBM cells were significantly upregulated, whereas those of the Bax and Caspase-3 were significantly downregulated (Figs. 6A, S3E). The gene discussed is BAX; the disease is glioblastoma.